In this study, MDD patients had significantly higher IL-4, IL-10, and IL-13 levels at W0 versus healthy volunteers and lower proinflammatory cytokine levels (IL-1β, IFN-γ, and IL-2). This evidence concerns the gene IL1B and major depressive disorder.